{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T07:05:42Z","timestamp":1789455942470,"version":"build-2803163510"},"reference-count":95,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100004663","name":"Taiwan Ministry of Science and Technology","doi-asserted-by":"crossref","award":["104-2628-E-007-001-MY3"],"award-info":[{"award-number":["104-2628-E-007-001-MY3"]}],"id":[{"id":"10.13039\/501100004663","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100004663","name":"Taiwan Ministry of Science and Technology","doi-asserted-by":"crossref","award":["105-2221-E-007-053-MY3"],"award-info":[{"award-number":["105-2221-E-007-053-MY3"]}],"id":[{"id":"10.13039\/501100004663","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100012553","name":"Chang Gung Memorial Hospital","doi-asserted-by":"crossref","award":["CMRPG3F0882"],"award-info":[{"award-number":["CMRPG3F0882"]}],"id":[{"id":"10.13039\/100012553","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","cell.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","bmn.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Trends in Biotechnology"],"published-print":{"date-parts":[[2018,3]]},"DOI":"10.1016\/j.tibtech.2017.11.004","type":"journal-article","created":{"date-parts":[[2017,12,11]],"date-time":"2017-12-11T17:21:13Z","timestamp":1513012873000},"page":"290-303","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":30,"title":["Point-of-Care Devices Using Disease Biomarkers To Diagnose Neurodegenerative Disorders"],"prefix":"10.1016","volume":"36","author":[{"given":"Ting-Yen","family":"Wei","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kuo-Hsuan","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kun-Ju","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Jen","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao-Min","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tibtech.2017.11.004_bib0005","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.jalz.2016.03.001","article-title":"2016 Alzheimer\u2019s disease facts and figures","volume":"12","author":"Alzheimer's","year":"2016","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.tibtech.2017.11.004_bib0010","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.1212\/WNL.0b013e31828726f5","article-title":"Alzheimer disease in the United States (2010\u20132050) estimated using the 2010 census","volume":"80","author":"Hebert","year":"2013","journal-title":"Neurology"},{"key":"10.1016\/j.tibtech.2017.11.004_bib0015","article-title":"Improving estimates of Parkinson\u2019s disease prevalence and incidence in the USA","volume":"29","author":"Beck","year":"2014","journal-title":"Mov. Disord."},{"key":"10.1016\/j.tibtech.2017.11.004_bib0020","doi-asserted-by":"crossref","first-page":"54","DOI":"10.3389\/fmolb.2015.00054","article-title":"Molecular diagnostics of neurodegenerative disorders","volume":"2","author":"Agrawal","year":"2015","journal-title":"Front. Mol. Biosci."},{"key":"10.1016\/j.tibtech.2017.11.004_bib0025","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1159\/000443738","article-title":"The prevalence of Huntington\u2019s disease","volume":"46","author":"Rawlins","year":"2016","journal-title":"Neuroepidemiology"},{"key":"10.1016\/j.tibtech.2017.11.004_bib0030","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1111\/j.1365-2796.2004.01386.x","article-title":"Multiple cognitive deficits during the transition to Alzheimer\u2019s disease","volume":"256","author":"Backman","year":"2004","journal-title":"J. Intern. Med."},{"key":"10.1016\/j.tibtech.2017.11.004_bib0035","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1007\/s004060050101","article-title":"Clinical features of Alzheimer\u2019s disease","volume":"249","author":"Forstl","year":"1999","journal-title":"Eur. Arch. Psychiatry Clin. Neurosci."},{"key":"10.1016\/j.tibtech.2017.11.004_bib0040","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1136\/jnnp.2007.131045","article-title":"Parkinson\u2019s disease: clinical features and diagnosis","volume":"79","author":"Jankovic","year":"2008","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.tibtech.2017.11.004_bib0045","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1749-6632.2003.tb07458.x","article-title":"Description of Parkinson\u2019s disease as a clinical syndrome","volume":"991","author":"Fahn","year":"2003","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.tibtech.2017.11.004_bib0050","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a008870","article-title":"Clinical approach to Parkinson\u2019s disease: features, diagnosis, and principles of management","volume":"2","author":"Massano","year":"2012","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"10.1016\/j.tibtech.2017.11.004_bib0055","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1038\/ng1297-404","article-title":"Huntingtin is required for neurogenesis and is not impaired by the Huntington\u2019s disease CAG expansion","volume":"17","author":"White","year":"1997","journal-title":"Nat. Genet."},{"key":"10.1016\/j.tibtech.2017.11.004_bib0060","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/519816","article-title":"Magnetic resonance spectroscopy: an in vivo molecular imaging biomarker for Parkinson\u2019s disease?","volume":"2014","author":"Ciurleo","year":"2014","journal-title":"BioMed Res. Int."},{"key":"10.1016\/j.tibtech.2017.11.004_bib0065","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1159\/000089137","article-title":"Measurement of thirteen biological markers in CSF of patients with Alzheimer\u2019s disease and other dementias","volume":"21","author":"Blasko","year":"2006","journal-title":"Dement. Geriatr. Cogn. Disord."},{"key":"10.1016\/j.tibtech.2017.11.004_bib0070","doi-asserted-by":"crossref","first-page":"R78","DOI":"10.1186\/gb-2013-14-7-r78","article-title":"A blood based 12-miRNA signature of Alzheimer disease patients","volume":"14","author":"Leidinger","year":"2013","journal-title":"Genome Biol."},{"key":"10.1016\/j.tibtech.2017.11.004_bib0075","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0126423","article-title":"MicroRNA profiling of CSF reveals potential biomarkers to detect Alzheimer\u2019s disease","volume":"10","author":"Denk","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.tibtech.2017.11.004_bib0080","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1002\/ana.22311","article-title":"Cerebrospinal fluid biomarkers for Parkinson disease diagnosis and progression","volume":"69","author":"Shi","year":"2011","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.tibtech.2017.11.004_bib0085","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1001\/archneurol.2012.1654","article-title":"Accuracy of a panel of 5 cerebrospinal fluid biomarkers in the differential diagnosis of patients with dementia and\/or parkinsonian disorders","volume":"69","author":"Hall","year":"2012","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.tibtech.2017.11.004_bib0090","doi-asserted-by":"crossref","first-page":"344","DOI":"10.3109\/08916934.2015.1008464","article-title":"Antiphospholipid autoantibodies as blood biomarkers for detection of early stage Alzheimer\u2019s disease","volume":"48","author":"McIntyre","year":"2015","journal-title":"Autoimmunity"},{"key":"10.1016\/j.tibtech.2017.11.004_bib0095","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1001\/archneur.60.9.1202","article-title":"Biochemical diagnosis of Alzheimer disease by measuring the cerebrospinal fluid ratio of phosphorylated tau protein to beta-amyloid peptide42","volume":"60","author":"Maddalena","year":"2003","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.tibtech.2017.11.004_bib0100","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/s13195-016-0225-7","article-title":"A digital enzyme-linked immunosorbent assay for ultrasensitive measurement of amyloid-beta 1-42 peptide in human plasma with utility for studies of Alzheimer\u2019s disease therapeutics","volume":"8","author":"Song","year":"2016","journal-title":"Alzheimers Res. Ther."},{"key":"10.1016\/j.tibtech.2017.11.004_bib0105","doi-asserted-by":"crossref","first-page":"2263","DOI":"10.1007\/s00216-009-3208-8","article-title":"Immuno-PCR-based quantification of multiple phosphorylated tau-epitopes linked to Alzheimer\u2019s disease","volume":"395","author":"Singer","year":"2009","journal-title":"Anal. Bioanal. Chem."},{"key":"10.1016\/j.tibtech.2017.11.004_bib0110","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.jneuroim.2015.04.014","article-title":"The interleukin 1 alpha, interleukin 1 beta, interleukin 6 and alpha-2-macroglobulin serum levels in patients with early or late onset Alzheimer\u2019s disease, mild cognitive impairment or Parkinson\u2019s disease","volume":"283","author":"Dursun","year":"2015","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.tibtech.2017.11.004_bib0115","doi-asserted-by":"crossref","DOI":"10.1038\/srep29038","article-title":"Monoclonal antibody with conformational specificity for a toxic conformer of amyloid beta42 and its application toward the Alzheimer\u2019s disease diagnosis","volume":"6","author":"Murakami","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.tibtech.2017.11.004_bib0120","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.nbd.2011.08.003","article-title":"Post mortem cerebrospinal fluid alpha-synuclein levels are raised in multiple system atrophy and distinguish this from the other alpha-synucleinopathies, Parkinson\u2019s disease and dementia with Lewy bodies","volume":"45","author":"Foulds","year":"2012","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.tibtech.2017.11.004_bib0125","doi-asserted-by":"crossref","first-page":"646","DOI":"10.3109\/08916930903074833","article-title":"Redox-reactive antiphospholipid antibody differences between serum from Alzheimer\u2019s patients and age-matched controls","volume":"42","author":"McIntyre","year":"2009","journal-title":"Autoimmunity"},{"key":"10.1016\/j.tibtech.2017.11.004_bib0130","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1002\/mds.25772","article-title":"Cerebrospinal fluid lysosomal enzymes and alpha-synuclein in Parkinson\u2019s disease","volume":"29","author":"Parnetti","year":"2014","journal-title":"Mov. Disord."},{"key":"10.1016\/j.tibtech.2017.11.004_bib0135","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.bbi.2014.09.011","article-title":"Plasma inflammatory biomarkers for Huntington\u2019s disease patients and mouse model","volume":"44","author":"Chang","year":"2015","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.tibtech.2017.11.004_bib0140","doi-asserted-by":"crossref","first-page":"2833","DOI":"10.1021\/pr0700753","article-title":"Proteomic profiling of plasma in Huntington\u2019s disease reveals neuroinflammatory activation and biomarker candidates","volume":"6","author":"Dalrymple","year":"2007","journal-title":"J. Proteome Res."},{"key":"10.1016\/j.tibtech.2017.11.004_bib0145","doi-asserted-by":"crossref","first-page":"369","DOI":"10.3233\/JHD-160213","article-title":"Plasma cytokine levels in relation to neuropsychiatric symptoms and cognitive dysfunction in Huntington\u2019s disease","volume":"5","author":"Bouwens","year":"2016","journal-title":"J. Huntingt. Dis."},{"key":"10.1016\/j.tibtech.2017.11.004_bib0150","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/S1474-4422(17)30124-2","article-title":"Neurofilament light protein in blood as a potential biomarker of neurodegeneration in Huntington\u2019s disease: a retrospective cohort analysis","volume":"16","author":"Byrne","year":"2017","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.tibtech.2017.11.004_bib0155","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1111\/jnc.13719","article-title":"Cerebrospinal fluid total tau concentration predicts clinical phenotype in Huntington\u2019s disease","volume":"139","author":"Rodrigues","year":"2016","journal-title":"J. Neurochem."},{"key":"10.1016\/j.tibtech.2017.11.004_bib0160","doi-asserted-by":"crossref","first-page":"7669","DOI":"10.1007\/s00216-016-9863-7","article-title":"Total alpha-synuclein levels in human blood cells, CSF, and saliva determined by a lipid-ELISA","volume":"408","author":"Abd-Elhadi","year":"2016","journal-title":"Anal. Bioanal. Chem."},{"key":"10.1016\/j.tibtech.2017.11.004_bib0165","doi-asserted-by":"crossref","first-page":"8","DOI":"10.3389\/fnins.2016.00008","article-title":"Application of an amyloid beta oligomer standard in the sFIDA assay","volume":"10","author":"Kuhbach","year":"2016","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.tibtech.2017.11.004_bib0170","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.cca.2017.01.010","article-title":"Nanoparticle standards for immuno-based quantitation of alpha-synuclein oligomers in diagnostics of Parkinson\u2019s disease and other synucleinopathies","volume":"466","author":"Herrmann","year":"2017","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.tibtech.2017.11.004_bib0175","first-page":"S176","article-title":"sFIDA: A sensitive diagnostic assay for quantification of alpha-synuclein aggregates","volume":"31","author":"Bujnicki","year":"2016","journal-title":"Mov. Disord."},{"key":"10.1016\/j.tibtech.2017.11.004_bib0180","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1515\/hsz-2016-0153","article-title":"Analysis of anticoagulants for blood-based quantitation of amyloid beta oligomers in the sFIDA assay","volume":"398","author":"Kravchenko","year":"2017","journal-title":"Biol. Chem."},{"key":"10.1016\/j.tibtech.2017.11.004_bib0185","doi-asserted-by":"crossref","first-page":"4771","DOI":"10.1002\/anie.201001005","article-title":"Paper-based ELISA","volume":"49","author":"Cheng","year":"2010","journal-title":"Angew. Chem."},{"key":"10.1016\/j.tibtech.2017.11.004_bib0190","doi-asserted-by":"crossref","first-page":"7857","DOI":"10.1021\/acsnano.5b03203","article-title":"Cellphone-based hand-held microplate reader for point-of-care testing of enzyme-linked immunosorbent assays","volume":"9","author":"Berg","year":"2015","journal-title":"ACS Nano"},{"key":"10.1016\/j.tibtech.2017.11.004_bib0195","doi-asserted-by":"crossref","first-page":"2499","DOI":"10.1039\/c0lc00021c","article-title":"Programmable diagnostic devices made from paper and tape","volume":"10","author":"Martinez","year":"2010","journal-title":"Lab Chip"},{"key":"10.1016\/j.tibtech.2017.11.004_bib0200","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.bios.2011.10.019","article-title":"Paper-based chemiluminescence ELISA: lab-on-paper based on chitosan modified paper device and wax-screen-printing","volume":"31","author":"Wang","year":"2012","journal-title":"Biosens. Bioelectron."},{"key":"10.1016\/j.tibtech.2017.11.004_bib0205","doi-asserted-by":"crossref","first-page":"3150","DOI":"10.1039\/c2lc40325k","article-title":"3D Origami-based multifunction-integrated immunodevice: low-cost and multiplexed sandwich chemiluminescence immunoassay on microfluidic paper-based analytical device","volume":"12","author":"Ge","year":"2012","journal-title":"Lab Chip"},{"key":"10.1016\/j.tibtech.2017.11.004_bib0210","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1373\/clinchem.2004.039347","article-title":"Simultaneous measurement of beta-amyloid(1\u201342), total tau, and phosphorylated tau (Thr181) in cerebrospinal fluid by the xMAP technology","volume":"51","author":"Olsson","year":"2005","journal-title":"Clin. Chem."},{"key":"10.1016\/j.tibtech.2017.11.004_bib0215","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1373\/clinchem.2005.051201","article-title":"Amino-truncated beta-amyloid42 peptides in cerebrospinal fluid and prediction of progression of mild cognitive impairment","volume":"51","author":"Vanderstichele","year":"2005","journal-title":"Clin. Chem."},{"key":"10.1016\/j.tibtech.2017.11.004_bib0220","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1016\/j.neurobiolaging.2006.12.010","article-title":"Multiplexed quantification of dementia biomarkers in the CSF of patients with early dementias and MCI: a multicenter study","volume":"29","author":"Lewczuk","year":"2008","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.tibtech.2017.11.004_bib0225","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1016\/j.jalz.2014.12.006","article-title":"CSF biomarkers for the differential diagnosis of Alzheimer\u2019s disease: a large-scale international multicenter study","volume":"11","author":"Ewers","year":"2015","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.tibtech.2017.11.004_bib0230","first-page":"1277","article-title":"Association of cerebrospinal fluid beta-amyloid 1\u201342, T-tau, P-tau181, and alpha-synuclein levels with clinical features of drug-naive patients with early Parkinson disease","volume":"70","author":"Kang","year":"2013","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.tibtech.2017.11.004_bib0235","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0018850","article-title":"Multiplexed immunoassay panel identifies novel CSF biomarkers for Alzheimer\u2019s disease diagnosis and prognosis","volume":"6","author":"Craig-Schapiro","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.tibtech.2017.11.004_bib0240","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1212\/01.wnl.0000271077.82508.a0","article-title":"Plasma and CSF serpins in Alzheimer disease and dementia with Lewy bodies","volume":"69","author":"Nielsen","year":"2007","journal-title":"Neurology"},{"key":"10.1016\/j.tibtech.2017.11.004_bib0245","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1007\/s00216-010-4019-7","article-title":"A hard microflow cytometer using groove-generated sheath flow for multiplexed bead and cell assays","volume":"398","author":"Thangawng","year":"2010","journal-title":"Anal. Bioanal. Chem."},{"key":"10.1016\/j.tibtech.2017.11.004_bib0250","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0034319","article-title":"Evaluation of portable point-of-care CD4 counter with high sensitivity for detecting patients eligible for antiretroviral therapy","volume":"7","author":"Manabe","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.tibtech.2017.11.004_bib0255","doi-asserted-by":"crossref","first-page":"11023","DOI":"10.1073\/pnas.0504921102","article-title":"Genome-wide expression profiling of human blood reveals biomarkers for Huntington\u2019s disease","volume":"102","author":"Borovecki","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.tibtech.2017.11.004_bib0260","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1016\/j.neurobiolaging.2006.08.004","article-title":"Transcriptional profiling of Alzheimer blood mononuclear cells by microarray","volume":"28","author":"Maes","year":"2007","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.tibtech.2017.11.004_bib0265","doi-asserted-by":"crossref","first-page":"109","DOI":"10.3233\/JAD-2010-101518","article-title":"A gene expression pattern in blood for the early detection of Alzheimer\u2019s disease","volume":"23","author":"Booij","year":"2011","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.tibtech.2017.11.004_bib0270","doi-asserted-by":"crossref","first-page":"121","DOI":"10.3233\/JAD-2010-101521","article-title":"A novel blood test for the early detection of Alzheimer\u2019s disease","volume":"23","author":"Rye","year":"2011","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.tibtech.2017.11.004_bib0275","doi-asserted-by":"crossref","first-page":"169","DOI":"10.3233\/JAD-2012-120637","article-title":"Validation of AclarusDx, a blood-based transcriptomic signature for the diagnosis of Alzheimer\u2019s disease","volume":"32","author":"Fehlbaum-Beurdeley","year":"2012","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.tibtech.2017.11.004_bib0280","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1097\/WAD.0000000000000022","article-title":"Distinctive RNA expression profiles in blood associated with Alzheimer disease after accounting for white matter hyperintensities","volume":"28","author":"Bai","year":"2014","journal-title":"Alzheimer Dis. Assoc. Disord."},{"key":"10.1016\/j.tibtech.2017.11.004_bib0285","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1186\/s12864-015-2058-3","article-title":"Blood transcriptomics of drug-naive sporadic Parkinson\u2019s disease patients","volume":"16","author":"Calligaris","year":"2015","journal-title":"BMC Genomics"},{"key":"10.1016\/j.tibtech.2017.11.004_bib0290","doi-asserted-by":"crossref","first-page":"93","DOI":"10.3233\/JAD-140606","article-title":"Blood genome-wide transcriptional profiles reflect broad molecular impairments and strong blood?brain links in Alzheimer\u2019s disease","volume":"43","author":"Naughton","year":"2015","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.tibtech.2017.11.004_bib0295","unstructured":"Erkers, J. (2016) Towards Automatic Smartphone Analysis for Point-of-Care Microarray Assays, MSc Dissertation UPTEC X 15 017, University of Uppsala"},{"key":"10.1016\/j.tibtech.2017.11.004_bib0300","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1186\/s13023-016-0475-2","article-title":"Common disease signatures from gene expression analysis in Huntington\u2019s disease human blood and brain","volume":"11","author":"Mina","year":"2016","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.tibtech.2017.11.004_bib0305","doi-asserted-by":"crossref","DOI":"10.1038\/srep34579","article-title":"Integrative transcriptomic meta-analysis of Parkinson\u2019s disease and depression identifies NAMPT as a potential blood biomarker for de novo Parkinson\u2019s disease","volume":"6","author":"Santiago","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.tibtech.2017.11.004_bib0310","doi-asserted-by":"crossref","first-page":"73","DOI":"10.3389\/fnagi.2017.00073","article-title":"Blood transcriptomic meta-analysis identifies dysregulation of hemoglobin and iron metabolism in Parkinson\u2019 disease","volume":"9","author":"Santiago","year":"2017","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.tibtech.2017.11.004_bib0315","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1146\/annurev.bioeng.10.061807.160524","article-title":"Point-of-care diagnostics for global health","volume":"10","author":"Yager","year":"2008","journal-title":"Annu. Rev. Biomed. Eng."},{"key":"10.1016\/j.tibtech.2017.11.004_bib0320","doi-asserted-by":"crossref","first-page":"5902","DOI":"10.1007\/s12035-015-9483-9","article-title":"Altered blood gene expression of tumor-related genes (PRKCB, BECN1, and CDKN2A) in Alzheimer\u2019s disease","volume":"53","author":"Antonell","year":"2016","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.tibtech.2017.11.004_bib0325","doi-asserted-by":"crossref","first-page":"37043","DOI":"10.18632\/oncotarget.6158","article-title":"Altered microRNA profiles in cerebrospinal fluid exosome in Parkinson disease and Alzheimer disease","volume":"6","author":"Gui","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.tibtech.2017.11.004_bib0330","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1136\/jnnp.2007.128728","article-title":"Detection of Huntington\u2019s disease decades before diagnosis: the Predict-HD study","volume":"79","author":"Paulsen","year":"2008","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.tibtech.2017.11.004_bib0335","doi-asserted-by":"crossref","first-page":"627","DOI":"10.3233\/JAD-2009-0996","article-title":"Gene expression as peripheral biomarkers for sporadic Alzheimer\u2019s disease","volume":"16","author":"Grunblatt","year":"2009","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.tibtech.2017.11.004_bib0340","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1016\/j.nbd.2011.05.023","article-title":"Gene expression profiling of peripheral blood leukocytes identifies and validates ABCB1 as a novel biomarker for Alzheimer\u2019s disease","volume":"43","author":"Chen","year":"2011","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.tibtech.2017.11.004_bib0345","doi-asserted-by":"crossref","first-page":"2225","DOI":"10.1093\/hmg\/ddr111","article-title":"Hsa-miR-34b is a plasma-stable microRNA that is elevated in pre-manifest Huntington\u2019s disease","volume":"20","author":"Gaughwin","year":"2011","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.tibtech.2017.11.004_bib0350","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1038\/ejhg.2014.281","article-title":"Huntington\u2019s disease biomarker progression profile identified by transcriptome sequencing in peripheral blood","volume":"23","author":"Mastrokolias","year":"2015","journal-title":"Eur. J. Hum. Genet."},{"key":"10.1016\/j.tibtech.2017.11.004_bib0355","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.parkreldis.2015.11.014","article-title":"Identification of a panel of five serum miRNAs as a biomarker for Parkinson\u2019s disease","volume":"22","author":"Ding","year":"2016","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.tibtech.2017.11.004_bib0360","doi-asserted-by":"crossref","first-page":"509","DOI":"10.3233\/JAD-160468","article-title":"Increased serum miR-206 level predicts conversion from amnestic mild cognitive impairment to Alzheimer\u2019s disease: a 5-year follow-up study","volume":"55","author":"Xie","year":"2017","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.tibtech.2017.11.004_bib0365","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0008898","article-title":"Joint genome-wide profiling of miRNA and mRNA expression in Alzheimer\u2019s disease cortex reveals altered miRNA regulation","volume":"5","author":"Nunez-Iglesias","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.tibtech.2017.11.004_bib0370","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.neulet.2017.02.045","article-title":"MicroRNA biomarkers of Parkinson\u2019s disease in serum exosome-like microvesicles","volume":"644","author":"Cao","year":"2017","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.tibtech.2017.11.004_bib0375","doi-asserted-by":"crossref","first-page":"455","DOI":"10.3109\/1354750X.2013.814073","article-title":"MicroRNA in Alzheimer\u2019s disease: an exploratory study in brain, cerebrospinal fluid and plasma","volume":"18","author":"Bekris","year":"2013","journal-title":"Biomarkers"},{"key":"10.1016\/j.tibtech.2017.11.004_bib0380","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.brainres.2014.04.026","article-title":"MicroRNA-135a and -200b, potential Biomarkers for Alzheimers disease, regulate beta secretase and amyloid precursor protein","volume":"1583","author":"Liu","year":"2014","journal-title":"Brain Res."},{"key":"10.1016\/j.tibtech.2017.11.004_bib0385","doi-asserted-by":"crossref","first-page":"7736","DOI":"10.1007\/s12035-016-0253-0","article-title":"MicroRNAs in cerebrospinal fluid as potential biomarkers for parkinson\u2019s disease and multiple system atrophy","volume":"54","author":"Marques","year":"2016","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.tibtech.2017.11.004_bib0390","doi-asserted-by":"crossref","first-page":"2257","DOI":"10.1073\/pnas.1423573112","article-title":"Network-based metaanalysis identifies HNF4A and PTBP1 as longitudinally dynamic biomarkers for Parkinson\u2019s disease","volume":"112","author":"Santiago","year":"2015","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.tibtech.2017.11.004_bib0395","doi-asserted-by":"crossref","first-page":"129","DOI":"10.3109\/1354750X.2015.1118544","article-title":"A panel of four decreased serum microRNAs as a novel biomarker for early Parkinson\u2019s disease","volume":"21","author":"Dong","year":"2016","journal-title":"Biomarkers"},{"key":"10.1016\/j.tibtech.2017.11.004_bib0400","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/1755-8794-3-15","article-title":"Peripheral blood gene expression patterns discriminate among chronic inflammatory diseases and healthy controls and identify novel targets","volume":"3","author":"Mesko","year":"2010","journal-title":"BMC Med. Genom."},{"key":"10.1016\/j.tibtech.2017.11.004_bib0405","doi-asserted-by":"crossref","first-page":"5772","DOI":"10.1007\/s12035-015-9484-8","article-title":"Peripheral blood microRNA expression profiles in Alzheimer\u2019s disease: screening, validation, association with clinical phenotype and implications for molecular mechanism","volume":"53","author":"Ren","year":"2016","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.tibtech.2017.11.004_bib0410","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1007\/s10072-017-2841-9","article-title":"Plasma levels of miR-137 and miR-124 are associated with Parkinson\u2019s disease but not with Parkinson\u2019s disease with depression","volume":"38","author":"Li","year":"2017","journal-title":"Neurol. Sci."},{"key":"10.1016\/j.tibtech.2017.11.004_bib0415","doi-asserted-by":"crossref","first-page":"611","DOI":"10.3233\/JAD-122404","article-title":"Prediction of mild cognitive impairment that evolves into Alzheimer\u2019s disease dementia within two years using a gene expression signature in blood: a pilot study","volume":"35","author":"Roed","year":"2013","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.tibtech.2017.11.004_bib0420","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1001\/archneur.63.6.883","article-title":"Preparing for preventive clinical trials: the Predict-HD study","volume":"63","author":"Paulsen","year":"2006","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.tibtech.2017.11.004_bib0425","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/625659","article-title":"Serum microRNA profiles serve as novel biomarkers for the diagnosis of Alzheimer\u2019s disease","volume":"2015","author":"Dong","year":"2015","journal-title":"Dis. Markers"},{"key":"10.1016\/j.tibtech.2017.11.004_bib0430","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1002\/cbf.3224","article-title":"Serum miR-221 serves as a biomarker for Parkinson\u2019s disease","volume":"34","author":"Ma","year":"2016","journal-title":"Cell Biochem. Funct."},{"key":"10.1016\/j.tibtech.2017.11.004_bib0435","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1039\/C6MB00699J","article-title":"Small RNA sequencing revealed dysregulated piRNAs in Alzheimer\u2019s disease and their probable role in pathogenesis","volume":"13","author":"Roy","year":"2017","journal-title":"Mol. Biosyst."},{"key":"10.1016\/j.tibtech.2017.11.004_bib0440","doi-asserted-by":"crossref","first-page":"16122","DOI":"10.18632\/oncotarget.15109","article-title":"Profile of 6 microRNA in blood plasma distinguish early stage Alzheimer\u2019s disease patients from non-demented subjects","volume":"8","author":"Nagaraj","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.tibtech.2017.11.004_bib0445","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/1750-1326-7-26","article-title":"A molecular signature in blood identifies early Parkinson\u2019s disease","volume":"7","author":"Molochnikov","year":"2012","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.tibtech.2017.11.004_bib0450","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1586\/17476348.2016.1164042","article-title":"The changing landscape in drug resistant-tuberculosis: an analysis of recent advances","volume":"10","author":"Monedero","year":"2016","journal-title":"Expert Rev. Respir. Med."},{"key":"10.1016\/j.tibtech.2017.11.004_bib0455","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.jmoldx.2017.03.004","article-title":"Highly multiplex real-time PCR-based screening for blood-borne pathogens on an openarray platform","volume":"19","author":"Grigorenko","year":"2017","journal-title":"J. Mol. Diagn."},{"key":"10.1016\/j.tibtech.2017.11.004_bib0460","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.bioelechem.2008.06.005","article-title":"Amyloid-beta detection with saccharide immobilized gold nanoparticle on carbon electrode","volume":"74","author":"Chikae","year":"2008","journal-title":"Bioelectrochemistry"},{"key":"10.1016\/j.tibtech.2017.11.004_bib0465","doi-asserted-by":"crossref","first-page":"2263","DOI":"10.1073\/pnas.0500024102","article-title":"Nanoscience enables ultrasensitive detection of Alzheimer\u2019s biomarker","volume":"102","author":"Keating","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.tibtech.2017.11.004_bib0470","doi-asserted-by":"crossref","first-page":"150","DOI":"10.3389\/fgene.2013.00150","article-title":"The detection of microRNA associated with Alzheimer\u2019s disease in biological fluids using next-generation sequencing technologies","volume":"4","author":"Cheng","year":"2013","journal-title":"Front. Genet."},{"key":"10.1016\/j.tibtech.2017.11.004_bib0475","series-title":"Data Mining: Practical Machine Learning Tools and Techniques","author":"Witten","year":"2016"}],"container-title":["Trends in Biotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167779917303025?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167779917303025?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,7]],"date-time":"2018-09-07T04:26:32Z","timestamp":1536294392000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167779917303025"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3]]},"references-count":95,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018,3]]}},"alternative-id":["S0167779917303025"],"URL":"https:\/\/doi.org\/10.1016\/j.tibtech.2017.11.004","relation":{},"ISSN":["0167-7799"],"issn-type":[{"value":"0167-7799","type":"print"}],"subject":[],"published":{"date-parts":[[2018,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Point-of-Care Devices Using Disease Biomarkers To Diagnose Neurodegenerative Disorders","name":"articletitle","label":"Article Title"},{"value":"Trends in Biotechnology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tibtech.2017.11.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}